Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00587938 · ClinicalTrials.gov registry record
BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 200
- Enrollment target
NCT00587938: Completed study, sponsored by Mayo Clinic.
NCT00587938 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00587938 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
Measurement of brain natriuretic peptide (BNP) in dyspneic patients increases diagnostic accuracy for congestive heart failure (CHF). Limited information is available regarding economic outcomes attributable to BNP assay. The aim of this study was to assess the economic impact of BNP assay in elderly dyspneic patients presenting to the emergency department (ED).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2003-12 |
| Est. Completion | 2005-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00587938
The ClinicalTrials.gov registry entry for NCT00587938 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00587938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00587938 about?
NCT00587938 is a clinical study titled "BNP Measurement Reduces Resource Utilization for Patients With CHF Admitted Thorough the ED". Measurement of brain natriuretic peptide (BNP) in dyspneic patients increases diagnostic accuracy for congestive heart failure (CHF). Limited information is available regarding economic outcomes attributable to BNP assay. The aim of this study was to assess the economic impact of BNP assay in elderl...
What is the current status of trial NCT00587938?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2003-12. Estimated completion is 2005-03.
Who is sponsoring clinical trial NCT00587938?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.